Clinical Trial Update: Organ Preservation Program Using Short-Course Radiation & FOLFOXIRI in Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update on an organ-preservation approach for rectal cancer using short-course radiation plus the FOLFOXIRI chemotherapy regimen, with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Irinotecan (Irinotecan)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Stanford University | Conditions: Rectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2025-02-25